首页 > 最新文献

Clinical calcium最新文献

英文 中文
[Prevention of osteoporosis during pregnancy and lactation period.] [孕期和哺乳期骨质疏松症的预防]
Pub Date : 2019-01-01 DOI: CliCa19018591
Hideaki Ishibashi

Post-pregnant osteoporosis, characterized by low back pain and vertebral fractures, is a relatively rare disease. For avoiding post-pregnant osteoporosis and decrease in bone mass during pregnancy or lactation period, it is necessary to obtain sufficient bone mass during the growth period and maintain bone mass in adulthood. From the results of the national nutrition and health survey, the total energy, protein, calcium intake of women aged 20s and 30s is the lowest in all ages. In addition, young women with exercise habits are less than 10%. In addition to the prevention of post-pregnant osteoporosis, to avoid future osteoporosis and fragility fractures of older age, it is necessary to promote young women to take measures such as adequate nutrition intake and exercise habits, considering bone health.

妊娠后骨质疏松症是一种相对罕见的疾病,以腰痛和椎体骨折为特征。为了避免孕后骨质疏松和妊娠期或哺乳期骨量下降,需要在生长期获得足够的骨量,并在成年期保持骨量。从全国营养和健康调查的结果来看,20多岁和30多岁妇女的总能量、蛋白质和钙摄入量是所有年龄段中最低的。此外,有运动习惯的年轻女性不足10%。除了预防孕后骨质疏松,避免今后老年骨质疏松和脆性骨折外,还需要促进年轻女性采取充足的营养摄入和运动习惯等措施,兼顾骨骼健康。
{"title":"[Prevention of osteoporosis during pregnancy and lactation period.]","authors":"Hideaki Ishibashi","doi":"CliCa19018591","DOIUrl":"https://doi.org/CliCa19018591","url":null,"abstract":"<p><p>Post-pregnant osteoporosis, characterized by low back pain and vertebral fractures, is a relatively rare disease. For avoiding post-pregnant osteoporosis and decrease in bone mass during pregnancy or lactation period, it is necessary to obtain sufficient bone mass during the growth period and maintain bone mass in adulthood. From the results of the national nutrition and health survey, the total energy, protein, calcium intake of women aged 20s and 30s is the lowest in all ages. In addition, young women with exercise habits are less than 10%. In addition to the prevention of post-pregnant osteoporosis, to avoid future osteoporosis and fragility fractures of older age, it is necessary to promote young women to take measures such as adequate nutrition intake and exercise habits, considering bone health.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 1","pages":"85-91"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36808014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The molecular mechanisms and the functions of new types of regulated cell death including necroptosis, ferroptosis, and pyroptosis.] [包括坏死性死亡、铁性死亡和焦性死亡在内的新型受调节细胞死亡的分子机制和功能]
Pub Date : 2019-01-01 DOI: 10.20837/4201902248
Sanae Miyake, Ryodai Shindo, Hiroyasu Nakano

Apoptosis is a prototype of regulated cell death and plays a crucial role in the development of various organs and maintaining tissue homeostasis. Recent studies have revealed that new types of regulated cell death, including necroptosis, ferroptosis, and pyroptosis are molecularly identified. In this review, we discuss the molecular mechanisms and the functions of new types of regulated cell death.

细胞凋亡是受调控的细胞死亡的一种形式,在各器官的发育和维持组织稳态中起着至关重要的作用。最近的研究表明,新的调节细胞死亡类型,包括坏死性死亡、铁性死亡和焦性死亡被分子鉴定出来。本文就新型调控细胞死亡的分子机制和功能作一综述。
{"title":"[The molecular mechanisms and the functions of new types of regulated cell death including necroptosis, ferroptosis, and pyroptosis.]","authors":"Sanae Miyake,&nbsp;Ryodai Shindo,&nbsp;Hiroyasu Nakano","doi":"10.20837/4201902248","DOIUrl":"https://doi.org/10.20837/4201902248","url":null,"abstract":"<p><p>Apoptosis is a prototype of regulated cell death and plays a crucial role in the development of various organs and maintaining tissue homeostasis. Recent studies have revealed that new types of regulated cell death, including necroptosis, ferroptosis, and pyroptosis are molecularly identified. In this review, we discuss the molecular mechanisms and the functions of new types of regulated cell death.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"248-253"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
[Coronary artery calcium:Its clinical utility in primary prevention.] 冠状动脉钙化:在初级预防中的临床应用
Pub Date : 2019-01-01 DOI: 10.20837/4201902215
Takashi Hisamatsu, Akira Fujiyoshi, Katsuyuki Miura

Coronary artery calcium, quantified by computed tomography scanning, is one of the well-known measures of subclinical atherosclerosis. Coronary artery calcium is considered an end result from the long-term exposure to risk factors. CAC has been shown to improve risk stratification in asymptomatic individuals with intermediate-risk(e.g., an option to facilitate decision making)for primary prevention of atherosclerotic cardiovascular disease in the US/western countries. Coronary artery calcium also represents a surrogate of atherosclerosis burden. However, the lack of evidence regarding issues such as costs or radiation exposure related to measuring coronary artery calcium warrants further studies.

冠状动脉钙化,通过计算机断层扫描量化,是众所周知的亚临床动脉粥样硬化的量度之一。冠状动脉钙化被认为是长期暴露于危险因素的最终结果。CAC已被证明可以改善无症状的中等风险个体的风险分层。(一种促进决策的选择)用于美国/西方国家动脉粥样硬化性心血管疾病的一级预防。冠状动脉钙也是动脉粥样硬化负荷的替代指标。然而,缺乏关于测量冠状动脉钙的成本或辐射暴露等问题的证据,值得进一步研究。
{"title":"[Coronary artery calcium:Its clinical utility in primary prevention.]","authors":"Takashi Hisamatsu,&nbsp;Akira Fujiyoshi,&nbsp;Katsuyuki Miura","doi":"10.20837/4201902215","DOIUrl":"https://doi.org/10.20837/4201902215","url":null,"abstract":"<p><p>Coronary artery calcium, quantified by computed tomography scanning, is one of the well-known measures of subclinical atherosclerosis. Coronary artery calcium is considered an end result from the long-term exposure to risk factors. CAC has been shown to improve risk stratification in asymptomatic individuals with intermediate-risk(e.g., an option to facilitate decision making)for primary prevention of atherosclerotic cardiovascular disease in the US/western countries. Coronary artery calcium also represents a surrogate of atherosclerosis burden. However, the lack of evidence regarding issues such as costs or radiation exposure related to measuring coronary artery calcium warrants further studies.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"215-223"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Role of AGEs-RAGE system in CKD-MBD.] [age - rage系统在CKD-MBD中的作用]
Pub Date : 2019-01-01 DOI: 10.20837/4201902193
Hironobu Fujisawa, Yosuke Nakayama, Kaoru Ueda, Kei Fukami

Abnormalities, such as hyperparathyroidism, vascular calcification, and osteoporosis, are devastating complications in patients with end-stage renal disease(ESRD). These abnormalities significantly affect the quality of life and prognosis. Therefore, controlling the abnormalities of chronic kidney disease-mineral and bone metabolism play an important role in these patients. Conventionally, calcium and phosphorus metabolism abnormalities have been mainly attributed to the development of vascular calcification, but preventing vascular calcification is still difficult even if calcium and phosphorus levels are controlled. Additionally, the mechanisms of the development and progression of vascular calcification in patients with ESRD are still unknown. Recently, advanced glycation end products(AGEs)have been known to be involved in the development and promotion of bone abnormality, such as bone embrittlement and vascular calcification. Therefore, blockade of AGEs and the receptor for AGE(RAGE)system may be a novel therapeutic strategy to improve the prognosis of patients with ESRD by inhibiting bone embrittlement and vascular calcification.

异常,如甲状旁腺功能亢进、血管钙化和骨质疏松症,是终末期肾病(ESRD)患者的毁灭性并发症。这些异常显著影响生活质量和预后。因此,控制慢性肾脏疾病的异常-矿物质和骨代谢在这些患者中起着重要的作用。通常认为钙磷代谢异常主要归因于血管钙化的发生,但即使钙磷水平得到控制,预防血管钙化仍然是一件困难的事情。此外,ESRD患者血管钙化的发生和进展机制尚不清楚。近年来,晚期糖基化终产物(AGEs)已被发现参与骨异常的发展和促进,如骨脆化和血管钙化。因此,阻断AGEs和AGE受体(RAGE)系统可能是一种新的治疗策略,通过抑制骨脆化和血管钙化来改善ESRD患者的预后。
{"title":"[Role of AGEs-RAGE system in CKD-MBD.]","authors":"Hironobu Fujisawa,&nbsp;Yosuke Nakayama,&nbsp;Kaoru Ueda,&nbsp;Kei Fukami","doi":"10.20837/4201902193","DOIUrl":"https://doi.org/10.20837/4201902193","url":null,"abstract":"<p><p>Abnormalities, such as hyperparathyroidism, vascular calcification, and osteoporosis, are devastating complications in patients with end-stage renal disease(ESRD). These abnormalities significantly affect the quality of life and prognosis. Therefore, controlling the abnormalities of chronic kidney disease-mineral and bone metabolism play an important role in these patients. Conventionally, calcium and phosphorus metabolism abnormalities have been mainly attributed to the development of vascular calcification, but preventing vascular calcification is still difficult even if calcium and phosphorus levels are controlled. Additionally, the mechanisms of the development and progression of vascular calcification in patients with ESRD are still unknown. Recently, advanced glycation end products(AGEs)have been known to be involved in the development and promotion of bone abnormality, such as bone embrittlement and vascular calcification. Therefore, blockade of AGEs and the receptor for AGE(RAGE)system may be a novel therapeutic strategy to improve the prognosis of patients with ESRD by inhibiting bone embrittlement and vascular calcification.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"193-198"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The association between vitamin D/calcium deficiency and cardiovascular events.] [维生素D/钙缺乏与心血管事件之间的关系。]
Pub Date : 2019-01-01 DOI: 10.20837/4201902185
Takayuki Hamano, Sayoko Yonemoto

According to some case reports, extreme hypocalcemia induced by vitamin D and calcium deficiency leads to heart failure. This rare clinical entity "Hypocalcemic cardiomyopathy" is also reported in elderly patients as well as infants. In patients with chronic kidney disease and heart failure, hypocalcemia is reported to predict worse outcome. Prescription of active vitamin D or its analogues is associated with lower rates of cardiovascular events in predialysis and dialysis patients, however indication biases often seen in observational studies cannot preclude the possibility that the benefit of these agents is limited to patients with high parathyroid hormone(PTH)levels. In fact, J-DAVID study, a randomized controlled trial from Japan, clearly showed that oral administration of alfacalcidol of 0.5 μg/day did not reduce cardiovascular events in hemodialysis patients with intact PTH<180 pg/mL.

根据一些病例报告,由维生素D和钙缺乏引起的极度低钙血症会导致心力衰竭。这种罕见的临床实体“低钙性心肌病”在老年患者和婴儿中也有报道。在慢性肾脏疾病和心力衰竭患者中,据报道,低钙血症预示着更糟糕的结果。在透析前和透析患者中,活性维生素D或其类似物的处方与较低的心血管事件发生率相关,然而,观察性研究中经常看到的适应症偏差不能排除这些药物的益处仅限于甲状旁腺激素(PTH)水平高的患者的可能性。事实上,来自日本的J-DAVID随机对照研究清楚地表明,口服0.5 μg/d的阿法骨化醇并没有减少血液透析患者完整PTH的心血管事件
{"title":"[The association between vitamin D/calcium deficiency and cardiovascular events.]","authors":"Takayuki Hamano,&nbsp;Sayoko Yonemoto","doi":"10.20837/4201902185","DOIUrl":"https://doi.org/10.20837/4201902185","url":null,"abstract":"<p><p>According to some case reports, extreme hypocalcemia induced by vitamin D and calcium deficiency leads to heart failure. This rare clinical entity \"Hypocalcemic cardiomyopathy\" is also reported in elderly patients as well as infants. In patients with chronic kidney disease and heart failure, hypocalcemia is reported to predict worse outcome. Prescription of active vitamin D or its analogues is associated with lower rates of cardiovascular events in predialysis and dialysis patients, however indication biases often seen in observational studies cannot preclude the possibility that the benefit of these agents is limited to patients with high parathyroid hormone(PTH)levels. In fact, J-DAVID study, a randomized controlled trial from Japan, clearly showed that oral administration of alfacalcidol of 0.5 μg/day did not reduce cardiovascular events in hemodialysis patients with intact PTH<180 pg/mL.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"185-191"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
[Coronary plaque evaluated by coronary CT(Including aortic valve calcification).] [冠状动脉CT评估冠状动脉斑块(包括主动脉瓣钙化)。]
Pub Date : 2019-01-01 DOI: 10.20837/4201902207
Akira Sato

Advances in CT scan revealed that the presence of calcified plaque by coronary CT and aortic calcification and aortic valve calcification by aortic CT are related to subsequent cardiovascular events. In particular, coronary calcification has many evidence related to cardiovascular events as a surrogate marker of plaque in atherosclerotic coronary arteries. From now on, by identifying atherosclerosis by calcium scanning with CT, it is necessary to consider drug treatment and lifestyle improvement, etc. for prevention of cardiovascular disease.

CT扫描的进展表明,冠状动脉CT显示钙化斑块,主动脉CT显示主动脉钙化和主动脉瓣钙化与随后的心血管事件有关。特别是,冠状动脉钙化作为冠状动脉粥样硬化斑块的替代标志物,有许多证据与心血管事件有关。从现在开始,通过CT钙扫描识别动脉粥样硬化,有必要考虑药物治疗和改善生活方式等预防心血管疾病。
{"title":"[Coronary plaque evaluated by coronary CT(Including aortic valve calcification).]","authors":"Akira Sato","doi":"10.20837/4201902207","DOIUrl":"https://doi.org/10.20837/4201902207","url":null,"abstract":"<p><p>Advances in CT scan revealed that the presence of calcified plaque by coronary CT and aortic calcification and aortic valve calcification by aortic CT are related to subsequent cardiovascular events. In particular, coronary calcification has many evidence related to cardiovascular events as a surrogate marker of plaque in atherosclerotic coronary arteries. From now on, by identifying atherosclerosis by calcium scanning with CT, it is necessary to consider drug treatment and lifestyle improvement, etc. for prevention of cardiovascular disease.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"207-213"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The frontier of adipocyte biology, cold environment induces thermogenic genes via epigenomic switch.] [脂肪细胞生物学前沿,低温环境通过表观基因组开关诱导产热基因]
Pub Date : 2019-01-01 DOI: 10.20837/4201903374
Juro Sakai

Epigenome, a record of the chemical changes to the DNA and histone proteins of an organism, is dynamically altered by environmental conditions and thus contributes to an adaptive mechanism for the given environmental stress. Among them, the cold environment is life-threatening to homeothermic animals. To combat, they induce thermogenic gene expression such as Ucp1 against cold stress. We recently revealed dual roles for the histone demethylase JMJD1A as a mediator of both acute and chronic thermogenic responses to cold stress, in two distinct thermogenic tissues, and through two distinct molecular mechanisms.

表观基因组是生物体DNA和组蛋白化学变化的记录,随着环境条件的变化而动态改变,因此有助于对给定环境压力的适应机制。其中,寒冷的环境对恒温动物是致命的。为了对抗寒冷,它们诱导产热基因表达,如Ucp1。我们最近揭示了组蛋白去甲基化酶JMJD1A在两种不同的产热组织中,通过两种不同的分子机制,作为对冷应激的急性和慢性产热反应的介质的双重作用。
{"title":"[The frontier of adipocyte biology, cold environment induces thermogenic genes via epigenomic switch.]","authors":"Juro Sakai","doi":"10.20837/4201903374","DOIUrl":"https://doi.org/10.20837/4201903374","url":null,"abstract":"<p><p>Epigenome, a record of the chemical changes to the DNA and histone proteins of an organism, is dynamically altered by environmental conditions and thus contributes to an adaptive mechanism for the given environmental stress. Among them, the cold environment is life-threatening to homeothermic animals. To combat, they induce thermogenic gene expression such as <i>Ucp1</i> against cold stress. We recently revealed dual roles for the histone demethylase JMJD1A as a mediator of both acute and chronic thermogenic responses to cold stress, in two distinct thermogenic tissues, and through two distinct molecular mechanisms.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 3","pages":"374-379"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37168093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Nomenclature on Cell Death, apoptosis and autophagic cell death.] [细胞死亡、凋亡和自噬细胞死亡的术语]
Pub Date : 2019-01-01 DOI: CliCa1901128134
Shigeomi Shimizu

Apoptosis had been considered as a sole form of cell death in living body. However, non-apoptotic forms of cell death have recently attracted more attention, and about 20 forms of non-apoptotic cell death have been identified. In this review, I introduce apoptosis and these non-apoptotic cell death, particularly autophagic cell death.

细胞凋亡一直被认为是生物体内细胞死亡的唯一形式。然而,近年来非凋亡形式的细胞死亡引起了更多的关注,目前已发现约20种非凋亡形式的细胞死亡。本文综述了细胞凋亡和非凋亡细胞死亡,特别是自噬细胞死亡。
{"title":"[Nomenclature on Cell Death, apoptosis and autophagic cell death.]","authors":"Shigeomi Shimizu","doi":"CliCa1901128134","DOIUrl":"https://doi.org/CliCa1901128134","url":null,"abstract":"<p><p>Apoptosis had been considered as a sole form of cell death in living body. However, non-apoptotic forms of cell death have recently attracted more attention, and about 20 forms of non-apoptotic cell death have been identified. In this review, I introduce apoptosis and these non-apoptotic cell death, particularly autophagic cell death.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 1","pages":"128-134"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36807460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Topics for basic research regarding osteoclasts and Wnt signals in ASBMR 2018.] 【ASBMR 2018关于破骨细胞和Wnt信号的基础研究课题】
Pub Date : 2019-01-01 DOI: CliCa19019498
Yasuhiro Kobayashi

This is a brief report regarding the topics about osteoclasts and Wnt signals presented in ASBMR 2018 held in Palais des congres de Montreal, Quebec in September 27-October 1, 2018.

这是一份关于2018年9月27日至10月1日在魁北克蒙特利尔会议宫举行的ASBMR 2018上提出的破骨细胞和Wnt信号主题的简要报告。
{"title":"[Topics for basic research regarding osteoclasts and Wnt signals in ASBMR 2018.]","authors":"Yasuhiro Kobayashi","doi":"CliCa19019498","DOIUrl":"https://doi.org/CliCa19019498","url":null,"abstract":"<p><p>This is a brief report regarding the topics about osteoclasts and Wnt signals presented in ASBMR 2018 held in Palais des congres de Montreal, Quebec in September 27-October 1, 2018.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 1","pages":"94-98"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36808015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prevention and treatment for vascular calcification in patients with diabetes mellitus.] 糖尿病患者血管钙化的防治
Pub Date : 2019-01-01 DOI: 10.20837/4201902225
Masahiro Yamamoto

It has been known that diabetes mellitus is known to have a high risk of cardiovascular diseases as well as osteoporosis. Prevention and treatment of vascular calcification in patients with diabeties mellitus by anti-osteoporosis agents is prospected bcause similar molecular mechanisms in bone tissue were found in calcified lesion in blood vessels. However, the anti-vascular calcification effect has not always been observed in clinical practice in contrast to basic research and animal experiments. More optimized clinical research desined for prevention of vascular calcification as primary outcome, such as applying elaborated method for detemination of calcified lesion, is needed.

众所周知,糖尿病患者患心血管疾病和骨质疏松症的风险很高。由于在血管钙化病变中发现了类似的骨组织分子机制,因此抗骨质疏松药物预防和治疗糖尿病患者血管钙化有一定的前景。然而,与基础研究和动物实验相比,在临床实践中并不总是观察到抗血管钙化作用。需要更多以预防血管钙化为主要结局的优化临床研究,如应用详细的钙化病变确定方法。
{"title":"[Prevention and treatment for vascular calcification in patients with diabetes mellitus.]","authors":"Masahiro Yamamoto","doi":"10.20837/4201902225","DOIUrl":"https://doi.org/10.20837/4201902225","url":null,"abstract":"<p><p>It has been known that diabetes mellitus is known to have a high risk of cardiovascular diseases as well as osteoporosis. Prevention and treatment of vascular calcification in patients with diabeties mellitus by anti-osteoporosis agents is prospected bcause similar molecular mechanisms in bone tissue were found in calcified lesion in blood vessels. However, the anti-vascular calcification effect has not always been observed in clinical practice in contrast to basic research and animal experiments. More optimized clinical research desined for prevention of vascular calcification as primary outcome, such as applying elaborated method for detemination of calcified lesion, is needed.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"225-230"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical calcium
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1